Counselling Service for Low-income EM in Hong Kong
The Effectiveness of Counselling on Mood Symptoms of Low-income Ethnic Minorities in Hong Kong: a Wait-list Randomised Controlled Trial
This study will recruit 120 ethnic minorities in Hong Kong from the Zubin Foundation (TZF) at the Ethnic Minority Well-being Centre (EMWBC), which is a service provider of EM mental health support in Hong Kong. This service provides counselling service and referrals to HA via the Integrated Community Centre for Mental Wellness (ICCMW) to psychiatrists. The service covers the South Asians population of approximately eighty-four thousands people in Hong Kong. Participants will be recruited by the Zubin Foundation through outreach activities screening and counselling will be conducted in partnering schools and NGOs (e.g., Yan Oi Tong in Tuen Mun and Yew Chung College of Early Childhood Education in Aberdeen).
The study aims to evaluate the effectiveness of counselling service for improving mood symptoms in EM, also to assess the effectiveness of counselling service in improving psychological functioning (i.e. resilience and rumination, self-compassion, self-efficacy and life satisfaction), social functioning and quality of life and to assess whether the counselling service is cost-effective and offers good value for money.
The study is a wait-list RCT. Participants will be randomly assigned into either the intervention group (n = 60) or the wait-list control group (n = 60) in a 1:1 ratio. Each participant in the intervention group will be paired up with a participant from the control group, the number of sessions and duration of waiting period varies depending on the severity of mood symptoms. Participants with mild to moderate mood symptoms will receive a maximum of 6 counselling sessions and will be assessed at baseline (T0, W1), at post
-treatment for counselling group (T1, W8), and after 2 booster sessions. Participants in the waiting list control group will receive the same counselling service after the counselling group completed the intervention. Participants with severe mood symptoms will receive a maximum of 10 counselling sessions and will be assessed at baseline (T0, W1), at post-treatment for counselling group (T1, W12), and after 2 booster sessions. Participants in the waiting list control group will receive the same counselling service after the counselling group completed the intervention.
This evaluation study will provide data to inform the government in mental health policy review and development.
Study Overview
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Yi Nam Suen, PhD
- Phone Number: 39179579
- Email: suenyn@hku.hk
Study Locations
-
-
-
Hong Kong, Hong Kong
- Recruiting
- University of Hong Kong
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- South Asian ethnic minorities (except domestic helper) in Hong Kong;
- 15 - 64 years
- reach at least the mild level of the Depression Anxiety Stress Scales - 21 Items in at least one of the following scores: the Depression Score (DASS-D), Anxiety Score (DASS-A) or Stress Score (DASS-S), or low Quality of Life score
- have sufficient proficiency in English, Hindi or Urdu to understand verbal instructions and give informed consent.
Exclusion Criteria:
- from high-income family (cut off ranges from HK$15K for single person family to HK$45K of 6 or more people family)
- mental conditions that require other treatment priorities (e.g., suicidal risk, substance abuse, current or past episodes of psychotic disorder, personality disorders)
- medical conditions that severely limit participation, comprehension, or adherence to treatment (e.g., epilepsy, dementia, terminal medical illness) and,
- current usage of antidepressant or mood stabilizers.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Counselling group
Counselling sessions will be conducted at the designated centers operated by the Zubin foundation.
According to the level of the DASS score, 6 to 10 sessions (based on the algorithm) of counselling service will be provided to the participants by three registered counsellors.
A lead counsellor will oversee all cases and services.
The counselling program consists of 6-10 60-minute sessions, and the sessions can be flexibly delivered over 1 to 2 weeks, ranging from one 60-minute session biweekly or weekly.
|
Participants with mild to moderate mood symptoms will receive a maximum of 6 counselling sessions and will be assessed at baseline (T0, W1), at post-treatment for counselling group (T1, W8), and after 2 booster sessions.
Participants in the waiting list control group will receive the same counselling service after the counselling group completed the intervention.
Participants with severe mood symptoms will receive a maximum of 10 counselling sessions and will be assessed at baseline (T0, W1), at post-treatment for counselling group (T1, W12), and after 2 booster sessions.
Participants in the waiting list control group will receive the same counselling service after the counselling group completed the intervention.
|
|
Other: Waiting group
For participants in the waiting list control group, they will receive monitoring service over phone calls during the 8-12 weeks wait period.
Counselling service will be offered after the post-treatment assessment.
|
Participants with mild to moderate mood symptoms will receive a maximum of 6 counselling sessions and will be assessed at baseline (T0, W1), at post-treatment for counselling group (T1, W8), and after 2 booster sessions.
Participants in the waiting list control group will receive the same counselling service after the counselling group completed the intervention.
Participants with severe mood symptoms will receive a maximum of 10 counselling sessions and will be assessed at baseline (T0, W1), at post-treatment for counselling group (T1, W12), and after 2 booster sessions.
Participants in the waiting list control group will receive the same counselling service after the counselling group completed the intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The change of the level of depressive symptoms
Time Frame: From Time 0 (baseline) to Time 1 (at week 8 or 12)
|
Measured by the Depression sub-scale of Depression, Anxiety and Stress Scale 21-item version.
The subscale has 7 items, each rated from 0 to 3, the total score will be doubled for interpretation of its severity.
The higher score indicates the more severe depressive symptoms.
|
From Time 0 (baseline) to Time 1 (at week 8 or 12)
|
|
The change of the level of anxiety symptoms
Time Frame: From Time 0 (baseline) to Time 1 (at week 8 or 12)
|
Measured by the Anxiety sub-scale of Depression, Anxiety and Stress Scale 21-item version.
The subscale has 7 items, each rated from 0 to 3, the total score will be doubled for interpretation of its severity.
The higher score indicates the more severe depressive symptoms.
|
From Time 0 (baseline) to Time 1 (at week 8 or 12)
|
|
The change of the level of stress symptoms
Time Frame: From Time 0 (baseline) to Time 1 (at week 8 or 12)
|
Measured by the Stress sub-scale of Depression, Anxiety and Stress Scale 21-item version.
The subscale has 7 items, each rated from 0 to 3, the total score will be doubled for interpretation of its severity.
The higher score indicates the more severe depressive symptoms.
|
From Time 0 (baseline) to Time 1 (at week 8 or 12)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The change of subjective quality of life
Time Frame: From Time 0 (baseline) to Time 1 (at week 8 or 12)
|
Measured by the Mental Component Summary (MCS) of Short Form 12 version 2. Min: 0, max:100.
The higher score indicates better mental health related subjective quality of life.
|
From Time 0 (baseline) to Time 1 (at week 8 or 12)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Eric Yu Hai Chen, MD, The University of Hong Kong
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EM RCT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.